ICYMI: WSJ and NYT highlight concerns with Part B International Pricing Index Model


Medicare Part B is a market-based system that has enabled millions of seniors and patients with disabilities to access needed medicines. Reimbursement for medicines in Part B is based on the Average Sales Price of a medicine, which reflects rebates and discounts negotiated in the commercial market and  Medicare Part B, subject to certain exceptions. Although this system has worked well at controlling costs for beneficiaries and the government, the Administration has proposed setting medicine prices in the United States based on the prices set by foreign governments with severely restricted access to new medicines. Many are questioning how the proposal would work.